FierceBiotech

Shares of Editas Medicine Inc (NASDAQ: EDIT) tumbled 20 percent Tuesday after the CEO of the genome editing company announced her resignation. Editas said Katrine Bosley will step down as president, CEO and board member while board member Cynthia Collins will run the company as interim CEO. The...

Shares of Endocyte, Inc. (NASDAQ: ECYT) were trading higher by more than 60 percent Tuesday afternoon at $5.82 on top of Monday's monster triple-digit-percentage return gain, but some analysts see even more upside. Wedbush's David Nierengarten upgraded Endocyte's stock rating Neutral to Outperform...

Shares of Paratek Pharmaceuticals Inc (NASDAQ: PRTK) soared by more than 30 percent on Wednesday after a Bloomberg report suggested the company is looking to sell itself to a larger peer. Sources close to the matter told Bloomberg that Paratek is still in the exploration phase and is consulting...

Shares of Amicus Therapeutics, Inc. (NASDAQ: FOLD) climbed 7 percent in the pre-market hours after a Wall Street analyst said the company could be bought for $22.50 a share with Sanofi SA (ADR) (NYSE: SNY) or Shire PLC (ADR) (NASDAQ: SHPG) touted as potential acquirers. Acquisition...

There are millions of tweets written every day. Benzinga sifts through the maelstrom of information to find the ten best tweets of the day that are either informative, insightful or just down right comical. 1. Jesse Colombo Jesse Colombo ( @TheBubbleBubble ) an analyst that was recognized for...